Table 1.
Qualitative susceptibility according to resistance (R) and susceptibility (S) patterns
| Phenotypical profile | TEC | AMP | CIP | STH | GEH | LNZ | QDA | TCY | n | % |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | S | S | R | R | S | S | S | R | 1 | 3.45 |
| 2 | R | R | R | R | S | S | S | R | 20 | 68.97 |
| 3 | R | R | R | R | S | S | S | S | 3 | 10.34 |
| 4 | R | R | R | S | S | S | S | S | 5 | 17.24 |
TEC teicoplanin, AMP ampicillin, CIP ciprofloxacin, STH streptomycin high load, GEH gentamicin high load, LNZ linezolid, QDA quinupristin-dalfopristin, TCY tetracycline. n: number of isolates expressing the target profile. %: percentage of isolates having the target phenotypical profile